(Total Views: 649)
Posted On: 06/15/2021 9:34:52 AM
Post# of 154912
CDiddy Wrote
How about #5- BLA for HIV Combo.
We are now approaching the year anniversary of the RTF, we passed the 3 year anniversary of the Phase 3 hitting our PE, and we don't have the fracking app together.
Meanwhile, we are chasing EUA's in 3rd world countries while COVID is in the 4th quarter in the USA (the guys with the money). As wealthier nations are starting to rally to help distribute vaccines, the virus will run its course before we can get trial data back from trials (Brazil) that haven't even started. I'm all for helping the world if we can, but as a shareholder, I want to sell product, period. We can't create sustainable revenues if we don't get full approval to sell Leronlimab for something, somewhere.
Quote:
We need some positive news. This slow grind is hard to watch.
We know that we have a special molecule. We just need to catch a break. Reinvigorate the investor base, get some new investors.
Trying to decide the order of potential catalysts:. What order do you think?
1). LH phase 2 data
2). Start of Brazil trials
3). Sizable Phillipines order
4). Other?
Read More: https://investorshangout.com/post/newpost/605...z6xrbTdR4b
How about #5- BLA for HIV Combo.
We are now approaching the year anniversary of the RTF, we passed the 3 year anniversary of the Phase 3 hitting our PE, and we don't have the fracking app together.
Meanwhile, we are chasing EUA's in 3rd world countries while COVID is in the 4th quarter in the USA (the guys with the money). As wealthier nations are starting to rally to help distribute vaccines, the virus will run its course before we can get trial data back from trials (Brazil) that haven't even started. I'm all for helping the world if we can, but as a shareholder, I want to sell product, period. We can't create sustainable revenues if we don't get full approval to sell Leronlimab for something, somewhere.
(9)
(0)
